FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3168672022> ?p ?o ?g. }

• W3168672022 endingPage "101139" @default.
• W3168672022 startingPage "101139" @default.
• W3168672022 abstract "Some studies reported stereotactic body radiotherapy (SBRT) has demonstrated superior therapeutic results than conventional radiotherapy. Nevertheless, this statement is controversial and the trial attempting to prove this is underway. We conducted this systemic review and meta-analysis aiming to combine the latest and most complete information about the survival outcomes and toxicities following SBRT for locally advanced pancreatic cancer (LAPC) and borderline resectable pancreatic cancer (BRPC). Items involving SBRT and pancreatic cancer were searched in PubMed, EMBASE, Cochrane Library, SCOPUS and Web of Science. Median overall survival (OS), 1/2/3-year OS, median progression-free survival (PFS), 1/2/3-year PFS and incidence of grade 3–5 toxicities were the endpoints of interest in this meta-analysis. These endpoint proportions were pooled and analyzed using R. For the LAPC series, the median OS was 14.1 months; pooled 1/2/3-year OS rates were 57%, 19% and 10%, respectively; the median PFS was 10 months; pooled 1/2/3-year PFS rates were 36%, 12% and 4%; pooled incidence rates of acute gastrointestinal (GI), acute hematologic and late GI toxicity (grade≥3) were 2%, 4% and 8%. For the BRPC series, the median OS was 17.5 months; pooled 1/2-year OS rates were 75% and 29%; the median PFS was 12.2 months; pooled 1/2-year PFS rates were 48% and 18%; the incidence rates of toxicity (grade ≥ 3) were all 0%. Our meta-analysis based on published results of OS, PFS and incidence rates of toxicity demonstrated that SBRT does not show desirable therapeutic result than the standard therapies for LAPC and BRPC." @default.
• W3168672022 created "2021-06-22" @default.
• W3168672022 creator A5001218285 @default.
• W3168672022 creator A5015552990 @default.
• W3168672022 creator A5036142741 @default.
• W3168672022 creator A5042394520 @default.
• W3168672022 creator A5052024256 @default.
• W3168672022 creator A5057323286 @default.
• W3168672022 creator A5060002817 @default.
• W3168672022 creator A5074403685 @default.
• W3168672022 date "2021-08-01" @default.
• W3168672022 modified "2023-09-27" @default.
• W3168672022 title "Survival outcome after stereotactic body radiotherapy for locally advanced and borderline resectable pancreatic cancer: A systematic review and meta-analysis" @default.
• W3168672022 cites W1563283949 @default.
• W3168672022 cites W1630759334 @default.
• W3168672022 cites W1972054401 @default.
• W3168672022 cites W2001678949 @default.
• W3168672022 cites W2015107633 @default.
• W3168672022 cites W2038962741 @default.
• W3168672022 cites W2068359620 @default.
• W3168672022 cites W2075527167 @default.
• W3168672022 cites W2085562092 @default.
• W3168672022 cites W2091193950 @default.
• W3168672022 cites W2101345979 @default.
• W3168672022 cites W2109736870 @default.
• W3168672022 cites W2146974261 @default.
• W3168672022 cites W2164019557 @default.
• W3168672022 cites W2345822778 @default.
• W3168672022 cites W2346921980 @default.
• W3168672022 cites W2524923212 @default.
• W3168672022 cites W2528163604 @default.
• W3168672022 cites W2534834821 @default.
• W3168672022 cites W2732234188 @default.
• W3168672022 cites W2734591476 @default.
• W3168672022 cites W2737789729 @default.
• W3168672022 cites W2791379462 @default.
• W3168672022 cites W2794474315 @default.
• W3168672022 cites W2810251642 @default.
• W3168672022 cites W2895220236 @default.
• W3168672022 cites W2899929486 @default.
• W3168672022 cites W2933649532 @default.
• W3168672022 cites W2955295727 @default.
• W3168672022 cites W2973123957 @default.
• W3168672022 cites W2982414952 @default.
• W3168672022 cites W2999417355 @default.
• W3168672022 doi "https://doi.org/10.1016/j.tranon.2021.101139" @default.
• W3168672022 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8188566" @default.
• W3168672022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34091293" @default.
• W3168672022 hasPublicationYear "2021" @default.
• W3168672022 type Work @default.
• W3168672022 sameAs 3168672022 @default.
• W3168672022 citedByCount "1" @default.
• W3168672022 countsByYear W31686720222021 @default.
• W3168672022 crossrefType "journal-article" @default.
• W3168672022 hasAuthorship W3168672022A5001218285 @default.
• W3168672022 hasAuthorship W3168672022A5015552990 @default.
• W3168672022 hasAuthorship W3168672022A5036142741 @default.
• W3168672022 hasAuthorship W3168672022A5042394520 @default.
• W3168672022 hasAuthorship W3168672022A5052024256 @default.
• W3168672022 hasAuthorship W3168672022A5057323286 @default.
• W3168672022 hasAuthorship W3168672022A5060002817 @default.
• W3168672022 hasAuthorship W3168672022A5074403685 @default.
• W3168672022 hasBestOaLocation W31686720221 @default.
• W3168672022 hasConcept C120665830 @default.
• W3168672022 hasConcept C121332964 @default.
• W3168672022 hasConcept C121608353 @default.
• W3168672022 hasConcept C126322002 @default.
• W3168672022 hasConcept C143998085 @default.
• W3168672022 hasConcept C203092338 @default.
• W3168672022 hasConcept C207103383 @default.
• W3168672022 hasConcept C2776478404 @default.
• W3168672022 hasConcept C2780210213 @default.
• W3168672022 hasConcept C2780739268 @default.
• W3168672022 hasConcept C3019894029 @default.
• W3168672022 hasConcept C44249647 @default.
• W3168672022 hasConcept C509974204 @default.
• W3168672022 hasConcept C535046627 @default.
• W3168672022 hasConcept C61511704 @default.
• W3168672022 hasConcept C71924100 @default.
• W3168672022 hasConcept C95190672 @default.
• W3168672022 hasConceptScore W3168672022C120665830 @default.
• W3168672022 hasConceptScore W3168672022C121332964 @default.
• W3168672022 hasConceptScore W3168672022C121608353 @default.
• W3168672022 hasConceptScore W3168672022C126322002 @default.
• W3168672022 hasConceptScore W3168672022C143998085 @default.
• W3168672022 hasConceptScore W3168672022C203092338 @default.
• W3168672022 hasConceptScore W3168672022C207103383 @default.
• W3168672022 hasConceptScore W3168672022C2776478404 @default.
• W3168672022 hasConceptScore W3168672022C2780210213 @default.
• W3168672022 hasConceptScore W3168672022C2780739268 @default.
• W3168672022 hasConceptScore W3168672022C3019894029 @default.
• W3168672022 hasConceptScore W3168672022C44249647 @default.
• W3168672022 hasConceptScore W3168672022C509974204 @default.
• W3168672022 hasConceptScore W3168672022C535046627 @default.
• W3168672022 hasConceptScore W3168672022C61511704 @default.
• W3168672022 hasConceptScore W3168672022C71924100 @default.
• W3168672022 hasConceptScore W3168672022C95190672 @default.
• W3168672022 hasIssue "8" @default.

• next